🇪🇺 Tradjenta in European Union

Tradjenta (LINAGLIPTIN) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/002110
  • Local brand name: Trajenta
  • Status: approved

Tradjenta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in European Union

Frequently asked questions

Is Tradjenta approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Tradjenta in European Union?

Boehringer Ingelheim is the originator. The local marketing authorisation holder may differ — check the official source linked above.